Introduction
============

Antimicrobial resistance (AMR) represents a significant global threat. It is useful to estimate the economic burden of AMR as these represent potential cost savings from reducing the problem.

Objectives
==========

To determine the impact of antimicrobial resistance on cost attributable to bloodstream infections (BSIs) caused by *Staphylococcus aureus* and Enterobacteriaceae from a European hospital perspective.

Methods
=======

We performed a multicentre retrospective cohort study including acute inpatient episodes at ten European hospitals in 2010 and 2011. BSIs were the time-varying exposure of interest, with *S. aureus* classified as methicillin-susceptible (MSSA) or resistant (MRSA), and Enterobacteriaceae as third-generation-cephalosporin-susceptible (3GCSE) or resistant (3GCRE). We used multistate models to estimate excess length-of-stay (LOS). For each bacteria/susceptibility combination, we computed the attributable cost of a single BSI as the product of excess LOS and the bed-day value. We used two contrasting bed-day values: an economic value obtained by contingent valuation and the accounting cost derived by dividing the annual hospital budget by the number of bed-days. To estimate the annual hospital costs of each BSI, these BSI costs were multiplied by the expected number of BSI cases per year. We performed a probabilistic sensitivity analysis to account for parameter uncertainty.

Results
=======

Our cohort included 606,649 patients. Third-generation-cephalosporin-resistance significantly increased the hazard of death (1.5 \[1.0--2.2\]), excess LOS (4.9 \[1.1--8.7\]) and cost compared to susceptible strains, whereas methicillin resistance did not. Whilst 3GCSE BSI was associated with the lowest per-infection cost (€320 \[95% credible interval, €80--€1,300\] or €4,000 \[€2,400--€6,700\] using economic and accounting valuations, respectively), their relative frequency resulted in equal highest annual cost with MSSA (€77,000 \[€19,000--€300,000\] or €970,000 \[€590,000--€1,600,000\] using economic and accounting valuations, respectively).

Conclusion
==========

While BSI with *S. aureus* has a greater impact on mortality, excess LOS and cost than Enterobacteriaceae per infection, the impact of antimicrobial resistance is greater amongst BSIs caused by Enterobacteriaceae.
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